Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-03-20

FDA Approved: PREGABALIN — Original Application (Chartwell RX, LLC)

View source ↗

Summary

FDA approves Chartwell RX, LLC's original ANDA for pregabalin, establishing a generic version of the drug.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pregabalin (Pregabalin)

Snippet

ORIG AP for PREGABALIN (PREGABALIN)